ArticleSignal transduction and targeted therapy2024

Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration.

Fenglian He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.